|
|
|
Volumn 26, Issue 3, 1999, Pages 316-323
|
|
Primary thyroid lymphoma
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
VINCRISTINE;
AIRWAY OBSTRUCTION;
B CELL LYMPHOMA;
CANCER CLASSIFICATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
DYSPHAGIA;
HISTOPATHOLOGY;
HOARSENESS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LARGE CELL LYMPHOMA;
MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
THYROID CANCER;
THYROID NODULE;
THYROIDITIS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
HUMANS;
LYMPHOMA, NON-HODGKIN;
NEOPLASM STAGING;
PROGNOSIS;
THYROID NEOPLASMS;
|
|
EID: 0033016660
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (181)
|
|
References (55)
|
